Cargando…
Could the decrease in the endothelial nitric oxide (NO) production and NO bioavailability be the crucial cause of COVID-19 related deaths?
Autores principales: | Ozdemir, Burak, Yazici, Ahmet |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7276137/ https://www.ncbi.nlm.nih.gov/pubmed/32534341 http://dx.doi.org/10.1016/j.mehy.2020.109970 |
Ejemplares similares
-
Asymmetric Dimethylarginine, Endothelial Nitric Oxide Bioavailability and Mortality in Sepsis
por: Davis, Joshua S., et al.
Publicado: (2011) -
Endothelial Dysfunction Is Associated with Decreased Nitric Oxide Bioavailability in Dysglycaemic Subjects and First-Degree Relatives of Type 2 Diabetic Patients
por: Ikonomidis, Ignatios, et al.
Publicado: (2022) -
Enhancement of Nitric Oxide Bioavailability by Modulation of Cutaneous Nitric Oxide Stores
por: Suschek, Christoph V., et al.
Publicado: (2022) -
Oleoyl-Lysophosphatidylcholine Limits Endothelial Nitric Oxide Bioavailability by Induction of Reactive Oxygen Species
por: Kozina, Andrijana, et al.
Publicado: (2014) -
Low Nitric Oxide Bioavailability Increases Renin Production in the Collecting Duct
por: Curnow, Andrew C., et al.
Publicado: (2020)